Table 1 Patients characteristics

Age category (year)

 11–20

23 (7.4)

18 (7.3)

5 (7.9)

 21–50

100 (32.3)

77 (31.2)

23 (36.5)

 51–70

115 (37.1)

96 (38.9)

19 (30.2)

  ≥ 71

72 (23.2)

56 (22.7)

16 (25.4)

Symptoms

 Pain/burning sensation

236 (76.1)

192 (77.7)

44 (69.9)

 Polyuria

155 (50.0)

127 (51.4)

28 (44.4)

 Urinary urgency

57 (18.4)

48 (19.4)

9 (14.3)

 Haematuria

38 (12.3)

33 (13.4)

5 (7.9)

 Flank pain

58 (18.7)

47 (19.0)

11 (17.5)

UTI in previous year

174 (56.1)

139 (56.3)

35 (55.6)

AB in previous year

183 (59.0)

146 (59.1)

37 (58.7)

 Amoxicillin

18 (5.8)

12 (4.8)

6 (9.5)

 Co-amoxiclav

6 (1.9)

4 (1.6)

2 (3.2)

 Doxycycline

10 (3.2)

10 (4.0)

0 (0.0)

 Nitrofurantoin

131 (42.3)

104 (42.0)

27 (42.9)

 Fosfomycin

42 (13.5)

34 (13.8)

8 (12.7)

 Trimethoprim

16 (5.2)

15 (6.1)

1 (1.6)

 Ciprofloxacin

21 (6.8)

16 (6.5)

5 (7.9)

 Norfloxacin

6 (1.9)

6 (2.4)

0 (0.0)

 Co-trimoxazole

2 (0.6)

2 (0.8)

0 (0.0)

 Clarithromycin

1 (0.3)

1 (0.4)

0 (0.0)

 Flucloxacillin

4 (1.3)

3 (1.2)

1 (1.6)

 Azithromycin

2 (0.6)

1 (0.4)

1 (1.6)

 Cefuroxime

1 (0.3)

1 (0.4)

0 (0.0)

 Metronidazole

1 (0.3)

0 (0.0)

1 (1.6)

Traveling abroad

53 (17.1)

45 (18.3)

8 (12.7)

Within Europe

37 (11.9)

31 (12.6)

6 (9.5)

Outside Europe

16 (5.2)

14 (5.7)

2 (3.2)

Empirical AB

148 (47.7)

128 (51.8)

20 (31.7)

 Amoxicillin

1 (0.3)

1 (0.4)

0 (0.0)

 Co-amoxiclav

1 (0.3)

0 (0.0)

1 (1.6)

 Nitrofurantoin

112 (36.1)

97 (39.3)

15 (23.8)

 Fosfomycin

19 (6.1)

16 (6.5)

3 (4.7)

 Trimethoprim

9 (2.9)

8 (3.2)

1 (1.6)

 Ciprofloxacin

5 (1.6)

5 (2.0)

0 (0.0)

 Norfloxacin

1 (0.3)

1 (0.4)

0 (0.0)

none

162 (52.3)

119 (48.2)

43 (68.3)